Literature DB >> 5549207

The absorption and metabolism of guanethidine in hypertensive patients requiring different doses of the drug.

C McMartin, P Simpson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5549207     DOI： 10.1002/cpt197112173

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

3.  Disposition of guanethidine during chronic oral therapy.

Authors:  J H Hengstmann; F C Falkner
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

Review 4.  A modern view of pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

Review 5.  Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension.

Authors:  F A Finnerty; R N Brogden
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

6.  The metabolism of [14C]-debrisoquine in man.

Authors:  J R Idle; A Mahgoub; M M Angelo; L G Dring; R Lancaster; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.